CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast

Product Details
Customization: Available
Powder: Yes
Customized: Customized
Still deciding? Get samples of $ !
Request Sample
Diamond Member Since 2024

Suppliers with verified business licenses

Audited Supplier

Audited by an independent third-party inspection agency

Importers and Exporters
The supplier has import and export rights
High Repeat Buyers Choice
More than 50% of buyers repeatedly choose the supplier
Fast Delivery
The supplier can deliver the goods within 15 days
Low MOQ
The MOQ for the supplier's products is 1
to see all verified strength labels (7)
  • CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
  • CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
  • CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
  • CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
  • CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
  • CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
Find Similar Products

Basic Info.

Model NO.
HB-Montelukast
Certification
GMP, HSE, ISO 9001, USP, BP
Suitable for
Adult
State
Powder
Purity
>99%
Test
HPLC
Packing
Rum, Aluminum Foil Bag
MOQ
1kg
Grade
Food
Storage
Cool Dry Place
Color
White Powder
Transport Package
Carton Box
Specification
99%
Trademark
Haibo
Origin
Shaanxi, China
HS Code
00000000
Production Capacity
5000000/Year

Product Description

CAS 151767-02-1 Montelukast Pharmaceutical Raw Material MontelukastCAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast

Montelukast was launched as Singulair in Mexico and Finland for the management of mild to moderate asthma inadequately controlled by inhaled corticosteroids and short-acting beta2-agonists. 

Montelukast  is suitable for relieving symptoms caused by allergic rhinitis

Montelukast is used for a number of conditions including asthma, exercise induced bronchospasm, allergic rhinitis, primary dysmenorrhoea and urticaria. 
Montelukast is mainly used as a complementary therapy in adults in addition to inhaled corticosteroids, if they alone do not bring the desired effect. 
Montelukast is also used to prevent allergic reactions and asthma flare-ups during the administration of intravenous immunoglobulin.

CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast



CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
Test Items Specification Results of Analysis
Appearance White or almost white crystalline powder Positive
Identificantion Litmus paper turns blue from red Conforms
Melting Point 184ºC~189ºC 185.0ºC~188.8ºC
Assay 98.0~102.0% 0.9995
PH 8.0~10.0 9.25
Specific rotation -65~-70° -65.30°
Loss on drying ≤0.5% 0.0002
Chloride ≤100ppm Pass
Heavy metals ≤10ppm Pass
Iron content ≤10ppm Pass
Related substances(TLC) ≤10ppm  Pass
Residue on ignition ≤0.1% 0.0002
Conclusion The specification comply with Enterprise standard
CAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast

CAS 151767-02-1 Montelukast Pharmaceutical Raw Material MontelukastCAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
CAS 151767-02-1 Montelukast Pharmaceutical Raw Material MontelukastCAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
CAS 151767-02-1 Montelukast Pharmaceutical Raw Material MontelukastCAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast
CAS 151767-02-1 Montelukast Pharmaceutical Raw Material MontelukastCAS 151767-02-1 Montelukast Pharmaceutical Raw Material MontelukastCAS 151767-02-1 Montelukast Pharmaceutical Raw Material Montelukast

Send your message to this supplier

*From:
*To:
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now
Contact Supplier